Online citations, reference lists, and bibliographies.
← Back to Search

CDX2, A Highly Sensitive And Specific Marker Of Adenocarcinomas Of Intestinal Origin: An Immunohistochemical Survey Of 476 Primary And Metastatic Carcinomas

Robert W Werling, H. Yaziji, C. Bacchi, A. Gown
Published 2003 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
CDX2 is a recently cloned homeobox gene that encodes an intestine-specific transcription factor, expressed in the nuclei of epithelial cells throughout the intestine, from duodenum to rectum. While expression of CDX2 protein in primary and metastatic colorectal carcinomas has been previously documented, neither the sensitivity nor the specificity of CDX2 expression, as determined by immunohistochemistry, for colorectal adenocarcinoma has been determined. We performed an immunohistochemical survey of 476 tumors with a monoclonal antibody, CDX2–88, including 89 tumors from the colon and duodenum and 95 tumors from other gastrointestinal sites, including the esophagus, stomach, pancreatobiliary system, gastrointestinal carcinoids, and liver. CDX2 was expressed uniformly (that is, in 76–100% of tumor cells) in all but one of the evaluated colorectal and duodenal tumors. High-level expression of CDX2 was also found, however, in mucinous ovarian carcinomas and adenocarcinomas primary to the urinary bladder of which 64% and 100% were positive, respectively. Gastric, gastroesophageal, and pancreatic adenocarcinomas and cholangiocarcinomas all showed similar, heterogeneous patterns of CDX2 expression. Most tumors in each group showed CDX2 expression by a minority of cells, whereas a substantial minority of cases in each group was completely negative and a smaller minority was uniformly positive. Gastrointestinal carcinoids gave similarly varied results, but the majority (58%) was negative. Hepatocellular carcinomas showed no expression of CDX2. Only very rare examples of carcinomas of the genitourinary and gynecologic tracts, breast, lung, and head and neck showed significant levels of CDX2 expression. In this study of primary and metastatic epithelial tumors, uniform CDX2 expression is demonstrated to be an exquisitely sensitive and highly, but incompletely, specific marker of intestinal adenocarcinomas. Compared with villin, a previously described marker of GI adenocarcinomas, CDX2 demonstrated superior sensitivity and comparable specificity. CDX2 expression can be seen, however, in selected non-GI adenocarcinomas such as mucinous ovarian carcinomas and adenocarcinomas of the urinary bladder.
This paper references
Coordinate expression of cytokeratins 7 and 20 define unique subsets of carcinoma
N-P Wang (1995)
10.1016/S0304-3835(01)00753-4
Ectopic expression of homeodomain protein CDX2 in intestinal metaplasia and carcinomas of the stomach.
Y. Bai (2002)
The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain.
D. Lazzaro (1991)
10.1016/S0002-9440(10)63074-X
Loss of CDX2 expression and microsatellite instability are prominent features of large cell minimally differentiated carcinomas of the colon.
T. Hinoi (2001)
Colonic hamartoma development by anomalous duplication in Cdx2 knockout mice.
Y. Tamai (1999)
Myogenic regulatory protein (MyoD1) expression in childhood solid tumors: diagnostic utility in rhabdomyosarcoma.
P. Dias (1990)
10.1002/(SICI)1098-2744(199812)23:4<234::AID-MC6>3.0.CO;2-J
Unique expression patterns and alterations in the intestinal protein villin in primary and metastatic pulmonary adenocarcinomas
Y. Nambu (1998)
10.1046/j.1365-2559.1998.00328.x
Value of a panel of antibodies to identify the primary origin of adenocarcinomas presenting as bladder carcinoma
Torenbeek (1998)
Expression of thyroid-specific transcription factors TTF-1 and PAX-8 in human thyroid neoplasms.
D. Fabbro (1994)
Distribution and pattern of expression of villin, a gastrointestinal-associated cytoskeletal protein, in human carcinomas: a study employing paraffin-embedded tissue.
C. Bacchi (1991)
10.1038/386084A0
Homeosis and intestinal tumours in Cdx2 mutant mice
K. Chawengsaksophak (1997)
10.1038/sj.onc.1201971
CDX2, a human homologue of Drosophila caudal, is mutated in both alleles in a replication error positive colorectal cancer
C. Wicking (1998)
10.1016/j.mce.2004.02.020
Estrogen and progesterone receptors in ovarian epithelial tumors
P. Lindgren (2004)
10.1016/0016-5085(88)90421-0
Localization of villin, a cytoskeletal protein specific to microvilli, in human ileum and colon and in colonic neoplasms.
A. West (1988)
10.1054/bjoc.2000.1544
The homeobox gene CDX2 in colorectal carcinoma: a genetic analysis
S. Sivagnanasundaram (2001)
Estrogen and progesterone receptors in epithelial ovarian tumors
K Glavind (1990)
10.1074/jbc.273.22.14030
Expression of the Cdx1 and Cdx2 Homeotic Genes Leads to Reduced Malignancy in Colon Cancer-derived Cells*
G. Mallo (1998)
10.1038/sj.bjc.6690068
Genomic structure and alterations of homeobox gene CDX2 in colorectal carcinomas
O. Yagi (1999)
Expression of myogenic regulatory proteins (myogenin and MyoD1) in small blue round cell tumors of childhood.
N. Wang (1995)
10.1007/BF02899208
Villin: a cytoskeletal protein and a differentiation marker expressed in some human adenocarcinomas
R. Moll (1987)
10.1073/PNAS.96.13.7318
Reprogramming of intestinal differentiation and intercalary regeneration in Cdx2 mutant mice.
F. Beck (1999)
10.1016/0959-8049(95)00560-9
TTF-1 gene expression in human lung tumours.
D. Fabbro (1996)
10.1046/j.1469-1809.1997.6150393.x
Cloning and chromosome assignment of the human CDX2 gene
F. Drummond (1997)
Coordinate expression of cytokeratin 7 and 20 defines unique subsets of carcinomas
N. Wang (1995)
10.1111/j.1699-0463.1990.tb05015.x
Estrogen and progesterone receptors in epithelial ovarian tumours
K. Glavind (1990)
Cdx-2 is a specific and sensitive marker of tumors of colonic origin
B Murer (2002)
Use of antibodies against estrogen and progesterone receptors to identify metastatic breast and ovarian carcinomas by conventional immunohistochemical and tyramide signal amplification methods.
O. Kaufmann (1998)
10.1002/(SICI)1097-0215(19970220)74:1<35::AID-IJC7>3.0.CO;2-1
Molecular cloning, sequencing and expression of the mRNA encoding human Cdx1 and Cdx2 homeobox. Down‐regulation of Cdx1 and Cdx2 mRNA expression during colorectal carcinogenesis
G. Mallo (1997)
Distribution and pattern of expression of villin, a gastrointestinal-associated cytoskeletal protein, in human carcinomas: a study employing paraffin-embedded tissue.
Bacchi Ce (1991)
Cytokeratins 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma.
K. Berezowski (1996)



This paper is referenced by
10.1038/labinvest.3700087
Aberrant expression of CDX2 is closely related to the intestinal metaplasia and MUC2 expression in intraductal papillary neoplasm of the liver in hepatolithiasis
A. Ishikawa (2004)
10.1111/j.1440-1827.2012.02810.x
Mucinous cystadenocarcinoma of the breast with a basal‐like immunophenotype
Yunte Deng (2012)
10.1097/01.pas.0000126856.09058.71
Immunophenotypic Differences Between Intestinal-type and Low-grade Papillary Sinonasal Adenocarcinomas: An Immunohistochemical Study of 22 Cases Utilizing CDX2 and MUC2
H. Cathro (2004)
10.1097/PAS.0b013e31829ab1c1
Loss of CDX2/CK20 Expression Is Associated With Poorly Differentiated Carcinoma, the CpG Island Methylator Phenotype, and Adverse Prognosis in Microsatellite-unstable Colorectal Cancer
J. Kim (2013)
10.1016/j.yexmp.2015.11.009
CDX2 downregulation is associated with poor differentiation and MMR deficiency in colon cancer.
J. Olsen (2016)
10.1016/B978-141604059-0.50026-6
CHAPTER 23 – Epithelial Neoplasms of the Large Intestine
M. Redston (2009)
10.1309/JAF3KVGJHQCJ1QF9
Expression of mucins, SIMA, villin, and CDX2 in small-intestinal adenocarcinoma.
M. Zhang (2007)
10.3346/jkms.2005.20.4.643
The Usefulness of CDX-2 for Differentiating Primary and Metastatic Ovarian Carcinoma: An Immunohistochemical Study Using a Tissue Microarray
M. Kim (2005)
10.6323/JCRP.2015.2.1.10
Concomitant Primary Lung Cancer and Metastatic Pulmonary Colorectal Cancer that Responded to Gemcitabine/Cisplatin/Bevacizumab Combination Therapy
Hung-Ming Chen (2015)
10.1002/bjs.11555
Gemcitabine‐based adjuvant chemotherapy in subtypes of ampullary adenocarcinoma: international propensity score‐matched cohort study
A. Moekotte (2020)
10.1043/1543-2165(2007)131[1561:POIMHD]2.0.CO;2
Panels of immunohistochemical markers help determine primary sites of metastatic adenocarcinoma.
S. Park (2007)
10.1016/J.ANNDIAGPATH.2006.06.002
Urinary bladder adenocarcinoma arising in a spina bifida patient.
M. Bitar (2007)
10.5772/27549
Homeobox Genes and Their Functional Significance in Ovarian Tumorigenesis
B. Trinh (2012)
10.7150/JCA.2.484
Metastatic Signet Ring Cell Carcinoma of the Bilateral Breasts and Ovaries from Gastrointestinal Tract in a Young Breastfeeding Female - A Case Report
Qingping Jiang (2011)
10.1155/2014/905478
Clear Cell Adenocarcinoma of the Colon: A Case Report and Review of the Literature
Christian Daniel Barrera-Maldonado (2014)
10.1007/s40944-019-0324-z
Synchronous Primary Cancer of Cervix and Non-genital Metastatic Tumor of Ovary: A Rare Case Report
Aruna Chhikara (2019)
10.1097/01.mpa.0000153615.55761.00
Aberrant Expression of cdx2 Homeobox Gene in Intraductal Papillary- Mucinous Neoplasm of the Pancreas But Not in Pancreatic Ductal Adenocarcinoma
Ta-Sen Yeh (2005)
10.1097/01.PGP.0000101141.31270.A0
The value of Cdx2 immunostaining in differentiating primary ovarian carcinomas from colonic carcinomas metastatic to the ovaries.
G. Groisman (2004)
10.1111/j.1440-1827.2004.01755.x
Mucinous cystadenocarcinoma of the breast coexisting with infiltrating ductal carcinoma
W. Chen (2004)
10.1158/1078-0432.CCR-05-1624
The Putative Tumor Suppressor Cdx2 Is Overexpressed by Human Colorectal Adenocarcinomas
M. Witek (2005)
10.1016/J.HUMPATH.2006.06.015
Expression of CDX2 in benign tissue and adenocarcinoma of the prostate.
Mehsati Herawi (2007)
10.1097/00125480-200607000-00004
The Diagnosis of Malignancy in Effusion Cytology: A Pattern Recognition Approach
T. C. Pereira (2006)
CHAPTER 1 INTRODUCTION AND OUTLINE OF THE THESIS HISTORICAL , CURRENT AND FUTURE PERSPECTIVES ON GASTROINTESTINAL AND PANCREATIC ENDOCRINE TUMORS : A TRIBUTE TO MASSON
C. Eeden (2009)
10.3389/fonc.2020.00008
CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup
Kristine Aasebø (2020)
10.1007/s00428-007-0444-1
Prognostic factors for ampullary adenocarcinomas: tumor stage, tumor histology, tumor location, immunohistochemistry and microsatellite instability
F. Sessa (2007)
10.1038/s41416-019-0560-0
CK7 and consensus molecular subtypes as major prognosticators in V600EBRAF mutated metastatic colorectal cancer
F. Loupakis (2019)
10.1371/journal.pone.0101735
Induction of Cancer Stem Cell Properties in Colon Cancer Cells by Defined Factors
Nobu Oshima (2014)
10.1016/J.PRP.2007.05.003
Differences in the expression of mucins in various forms of cystitis glandularis.
L. Janković Veličković (2007)
10.1517/14656566.4.7.1083
Pathological staging and therapy of oesophageal and gastric cancer
P. Debruyne (2003)
10.1016/j.yexcr.2009.01.006
Cdx2 and the Brm-type SWI/SNF complex cooperatively regulate villin expression in gastrointestinal cells.
N. Yamamichi (2009)
10.1038/s41379-020-0634-9
Mismatch repair phenotype determines the implications of tumor grade and CDX2 expression in stage II–III colon cancer
K. E. Hestetun (2020)
10.4132/jptm.2019.03.25
Rectal Invasion by Prostatic Adenocarcinoma That Was Initially Diagnosed in a Rectal Polyp on Colonoscopy
Ghilsuk Yoon (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar